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Purpose: A number of studies, including systematic reviews, show beneficial effects
of psychosocial interventions for people with diabetes mellitus; however, they have not
been assessed using meta-analysis. The purpose of this meta-analysis of randomized
controlled trials is to investigate the effects of psychosocial interventions on depressive
and anxiety symptoms, quality of life and self-efficacy in individuals with diabetes mellitus.
Methods: The databases Pubmed, MEDLINE, CINAHL, PsycINFO, Scopus, Web of
Science and SocINDEX were searched with no year restriction. Eligible studies were
randomized controlled trials published in English that included individuals diagnosed with
diabetes mellitus, aged 18 years or above, who engaged in a psychosocial intervention,
with outcome measures addressing depressive or anxiety symptomology, quality of life
or self-efficacy. Eligible studies needed to compare the intervention to usual care. Study
selection was completed using Covidence and meta-analysis was undertaken using
Comprehensive Meta-Analysis software.
Results: Seven studies were included in the meta-analysis. Five studies investigated
the effects of psychosocial interventions and showed a medium to large benefit for
depressive symptoms (SMD: −0.70; CI: −1.27, −0.13) which persisted at follow
up (SMD: −1.54, CI: −2.97, −0.12). Similar results were not seen immediately
post-intervention in the three studies that assessed anxiety symptoms (SMD: −0.30;
CI: −0.69, 0.10); however, a medium beneficial effect was seen at follow up (SMD =
−0.61, CI = −0.92 to −0.31). Small benefits were seen in the three studies assessing
quality of life outcomes (SMD: 0.30, CI: 0.06, 0.55). No benefit was seen in the two
studies assessing self-efficacy (SMD: 0.23, CI: −0.11, 0.57).
Conclusions: The results of the current study provide preliminary evidence that
psychosocial interventions, compared to usual care, reduce depressive symptoms, and
may improve quality of life in individuals with diabetes. However, only a few studies were
included and the clinical significance of these findings is unknown.
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INTRODUCTION
The worldwide burden of diagnosed diabetes mellitus (DM)
was approximately 422 million in 2014 (NCD-RisC, 2016). This
number is expected to reach 592 million by 2035 (Guariguata
et al., 2014) and an additional 174 million individuals are
estimated to have undiagnosed DM (Beagley et al., 2014). In
2012, the total costs associated with the treatment of DM in the
United Kingdom was £13.7 billion (Kanavos et al., 2012) and
$245 billion in the United States (American Diabetes Association,
2013). Given the high prevalence of DM and associated impact on
individuals and communities, it is important to understand the
factors influencing wellbeing to achieve the best possible quality
of life (QoL) for individuals with DM.
One factor affecting QoL in individuals with DM is the
development of depression and anxiety. Depressive and anxiety
disorders are highly prevalent among individuals with chronic
disease (Moussavi et al., 2007), including DM. Clinical depression
affects approximately 12% of individuals with Type I diabetes
and 19% of individuals with Type II diabetes (Roy and Lloyd,
2012), while generalized anxiety disorder affects approximately
14% of individuals with DM (Grigsby et al., 2002). Furthermore,
up to 31% of people with DM experience sub-clinical levels of
depression (Anderson et al., 2001) and up to 40% experience
sub-clinical levels of anxiety (Grigsby et al., 2002), which also
negatively influence health outcomes and management behavior
(Gonzalez et al., 2008). Depression and anxiety are highly
comorbid with one another, sharing a similar etiology and
neurobiology (Neale and Kendler, 1995). Anxiety is the single
strongest predictor of depression onset (Mathew et al., 2011), and
while neurochemical differences exist between the conditions,
recent studies suggest that depression and anxiety may be
overlapping syndromes, existing on a continuum (Baldwin et al.,
2002). Aside from impairing overall QoL and wellbeing, DM-
associated depression impairs functional ability (Smith and
Schmitz, 2014) and compromises glycaemic control (Anderson
et al., 2002), whilst being associated with increased risks of
hospitalization (Davydow et al., 2013), dementia (Katon et al.,
2012) and mortality (Hofmann et al., 2013). Accordingly, the
incorporation of psychological wellbeing in the management of
DM is commonplace in national standards of care (Craig et al.,
2011).
Social support is an important predictor of outcomes in
DM (Strom and Egede, 2012). Social support from peers and
other individuals is associated with improved metabolic control
(Trento et al., 2001), clinical outcomes (Strom and Egede,
2012), increased physical activity (Keyserling et al., 2002),
DM knowledge (Gilden et al., 1992), adherence to healthy
behavior regimes (Strom and Egede, 2012) and decreased DM
related distress (Baek et al., 2014). Reduced social support and
depression often coexist, with the two sharing a bidirectional
relationship (Lett et al., 2005). A low level of social support
is an important contributing factor to DM-related depression,
whilst depression reciprocally contributes to lowered levels
of social support (Sacco and Yanover, 2006). The interplay
between social support and depression indicates the importance
of utilizing interventions that address social support when
treating depression in individuals with DM. Psychological
interventions such as cognitive behavioral therapy have been
shown to be effective in the treatment of depression in
DM (Baumeister et al., 2012). A systematic review of eight
studies using various psychological interventions, including
cognitive behavioral therapy and psychodynamic supportive
therapy, demonstrated that these reduced depression severity
and remission rates in both the short and medium term, in
individuals with DM (Baumeister et al., 2012). Therefore, both
psychological interventions and social support are important in
the treatment of depression.
In non-DM populations, psychosocial interventions have
been shown to decrease depressive and anxiety symptoms
(Jacobsen and Jim, 2008; Forsman et al., 2011a,b). Indeed,
our group has previously evaluated the effect of psychosocial
interventions on depression and anxiety symptoms in individuals
with cardiovascular disease. In a meta-analysis of six eligible
randomized controlled trials (RCTs), we found a small significant
benefit for psychosocial interventions on depressive symptoms
(Ski et al., 2015).
Harkness et al. (2010) explored the impact of a diverse range
of lifestyle intervention to manage diabetes or psychological
intervention to manage mental health in people with DM,
using systematic review and meta-analysis. The authors reported
that no specific characteristics of lifestyle or psychological
interventions predicted substantial benefits in physical and
mental health outcomes. Harkness et al. (2010), however did
not restrict their analysis to psychosocial interventions, defined
as any intervention that combines both psychological and
social components (Thompson and Ski, 2013). Few studies
have been conducted to evaluate interventions comprising both
psychological and social support enhancing components for
depression and anxiety in people with DM. One systematic
review included 10 qualitative studies, including psychosocial
interventions, aimed at reducing depression in individuals with
DM (Kok et al., 2015). While the results of this review study
showed promising effects (Kok et al., 2015), no meta-analysis
has been undertaken of RCTs including strictly psychosocial
interventions. Therefore, the aim of the present study was to
assess the effects of psychosocial interventions in the context of
DM. Specifically, we aimed to conduct a systematic review and
meta-analysis of RCTs investigating the effects of psychosocial
interventions on depression and anxiety as well as QoL
and self-efficacy, compared to usual care (UC) in individuals
with DM.
MATERIALS AND METHODS
Data Sources and Search Strategy
This study was conducted following the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA)
guidelines/protocol (Moher et al., 2010). A prospective protocol
for the systematic review was not previously published. For two
articles authors were contacted to request clarification as to
whether group assignment was randomized (Trozzolino et al.,
2003) or if the intervention delivered incorporated a social
component or not (Simson et al., 2008). These authors did not
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respond and we were unable to determine if the studies met our
inclusion criteria. Thus, we could not include these studies in the
review or meta-analysis.
Eligible studies were randomized controlled trials (RCTs)
published in English that included individuals diagnosed with
DM only (no requirement for a diagnosis of depression or
anxiety) who engaged in a psychosocial intervention compared
to usual care. Eligible studies were required to compare the
intervention to usual care on at least one of the following
outcomes: depressive or anxiety symptomology, QoL or self-
efficacy. Other outcomes collected were body mass index (BMI),
hemoglobin A1c (HbA1c), social support, and fasting blood
glucose (FBG). A psychosocial intervention is defined as any
intervention that combines psychological and social components
(Thompson and Ski, 2013). Psychological components would
be those pertaining to an individual’s behavior and mind
inclusive of cognition and emotion, e.g., cognitive behavioral
therapy, motivational interviewing, or psycho-education. Social
components would be those pertaining to social support or
building interpersonal skills. However, it is acknowledged that
these components may vary in the literature. Review papers, non-
randomized trials, case series, and dissertations were excluded.
Eligible studies included participants over 18 years of age.
Interventions could be administered by any personnel and be
implemented through a range of modes, e.g., face to face,
telephone, telehealth or online. The primary outcomes were
depressive or anxiety symptoms. Secondary outcomes were QoL
and self-efficacy.
Searches were undertaken in January 2016 and updated in
March 2017. Articles were obtained by searching electronic
databases: PubMed, MEDLINE, CINAHL, PsycINFO, Scopus,
Web of Science and SocINDEX. Conference abstracts or trial
databases were not searched as we aimed only to include
complete RCTs that provided sufficient data for inclusion and
risk of bias assessment. Databases were searched for articles
with no year restriction and containing the specific title or
MeSH words, “Diabet∗,” or “glucose,” or “hyperglycemia,” or
“hypoglycemia,” or “glycohemoglobin,” or “metabolic syndrome,”
or “insulin” and the title/abstract or MeSH words “psych∗,”
or “motivational interviewing,” or “motivational behavior,”
or “motivational behavior,” or “behavior interviewing,” or
“behavior interviewing,” or “behavior change,” or “behavior
change,” or “motivational change,” or “non-invasive change,” or
“intervention,” and the title/abstract or MeSH word “depress∗,”
or “anxi∗,” or “melancholia,” or “dysthymia,” or “mood,” or
“quality of life,” or “self-efficacy,” or “coping,” or “stress.” In
an attempt to identify as many potentially eligible studies as
possible, the term “RCT” was not a filter in the initial search
strategy. We deliberately used broad search terms in an attempt
to capture as many interventions that might contain both a
psychological and social component as possible. While this
method of searching also identified many irrelevant studies, it
ensured that we captured as many potentially eligible studies
as possible. The terms “psych∗” and “intervention,” for example
were broad enough to capture both relevant and irrelevant
studies. We felt that the search term “non-invasive change”
for example was likely to capture studies with an intervention
containing a psychological or social support aspect, as this
term has been used in previous literature to describe “any
treatment or action, based on clinical judgment and knowledge,
that healthcare professionals (physicians, nurses, psychologists,
physiotherapists, occupational therapists, dieticians) perform to
enhance patient well-being or quality of life (Rueda et al.,
2011).” The terms “behavior change,” and “motivational change”
have been used in the literature to describe interventions
containing a psychological aspect (Wade et al., 2009; Michie
et al., 2011). Conference abstracts and technical reports were
also excluded as they were not likely to include the detailed
information required for assessment of bias or meta-analysis
inclusion.
Study Selection
Sourced studies were imported into Covidence online software
(https://www.covidence.org) and assessed for full text eligibility
based on title/abstract by two independent reviewers (MCP,
ZMJ); disagreements were resolved through discussion or by
consulting a third reviewer (CFS).
Data Extraction and Quality Assessment
Relevant data were extracted from each study using a predesigned
data extraction form, including study design, country
undertaken, aims, ethical information, studied outcomes, sample
size and participant characteristics. Intervention characteristics
included delivery method, components, personnel involved,
duration and follow up. The mean (M), standard deviation
(SD), and sample size (n) were extracted. Study authors were
contacted if published data were incomplete or unclear. In
two studies the authors were contacted and they advised that
individuals collecting outcome measures were blinded (D’Eramo
Melkus et al., 2010; Rosland et al., 2015). In two studies relevant
means and standard deviations for outcomes of interest were
not reported in the text and were provided by the authors upon
request (completers) (D’Eramo Melkus et al., 2010; Stoop et al.,
2015). Data were extracted independently by two reviewers and
disagreements were resolved through discussion or by consulting
a third reviewer.
Methodological quality of the studies was assessed
independently by two reviewers using the Cochrane
Collaboration’s risk of bias assessment tool (Cochrane
Collaboration, 2011). Due to the nature of the studies reviewed,
the blinding of participants and personnel (administering
the intervention) domain was not assessed in this review. To
best capture the current state and quality of research in this
field, papers were not included or excluded based on quality
assessment, and thus all eligible articles were included. Grades
of Recommendation, Assessment, Development and Evaluation
(GRADE) were assessed using the GRADE working group
recommendations as published in the Cochrane Handbook
(Cochrane Collaboration, 2011). We considered five factors
when assessing the quality of evidence: (1) risk of bias, (2)
heterogeneity, (3) population, intervention, comparison,
outcomes (PICO) (4) precision, and (5) publication bias
(Cochrane Collaboration, 2011).
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Summary Measures
For the meta-analysis we report the raw difference in means
when the outcome is reported on the same meaningful scale in
all studies The standardized mean difference (SMD) was used
in place of mean difference when studies included in the meta-
analysis used different outcome measures and thus the different
scales used were not comparable in raw form (Borenstein et al.,
2009). The SMD, is where the mean difference in each study is
divided by the standard deviation (SD) to create an index that is
comparable across studies (Borenstein et al., 2009). The sample
estimate of the SMD was Hedges G (g), which corrects for bias
due to small sample size. A small effect is considered 0.2, medium
0.5 and large 0.8 (Nakagawa and Cuthill, 2007; Borenstein et al.,
2009). In studies where multiple outcomes were used to measure
the depression, anxiety, or QoL outcomes, composite scores
using the mean of the various outcomes were used.
Data Synthesis and Analysis
Meta-analysis was undertaken using Comprehensive Meta-
Analysis (CMA) software version 3 (CMA, Biostat, USA).
The primary analysis compared the effect of the intervention
(psychosocial intervention) with UC groups on depression,
anxiety, QoL and self-efficacy scores. Other extracted outcomes
were body mass index (BMI), hemoglobin A1c (HbA1c), social
support, and fasting blood glucose (FBG). The Q statistic was
used to assess if effect size varied across studies and the p-
value used to determine statistical significance was 0.10. The
proportion of the observed variance reflects differences in true
effect sizes rather than sampling error as shown by the I2 statistic
(Borenstein et al., 2009). A funnel plot was used to ascertain any
publication bias, as shown in Supplementary Figure 1. Sensitivity
analyses were performed using “one study removed analysis” to
detect whether the observed effect was unduly influenced by any
single study. All studies were sampled from a universe of possible
studies defined by the inclusion/exclusion. A random effects
model was used in all analysis, weighting the studies based on the
sample size/standard error. When pre-post correlations were not
reported in the published paper, we conducted sensitivity analysis
using a correlation of 0 and a correlation of 0.9, and found the
results of our primary outcomes of interest to be the same, thus
we used a 0 correlation for all analyses.
RESULTS
We initially retrieved 1,618 papers, 981 were duplicates, leaving
637 for screening. 612 were excluded from title/abstract screening
leaving 25 for full text review. Seven of these were included in the
study. The PRISMA flow diagram illustrates the reasons for study
exclusions (Figure 1).
Study Descriptions
Table 1 shows that the RCTs were two-group, parallel designs.
Sample sizes ranged from 18 to 111 and participant ages ranged
from 45 to 64 years. The percentage of women ranged from 23 to
100%. In all but one study (Kuijer et al., 2007) participants were
diagnosed with type II diabetes. In one trial, 56% of participants
were diagnosed with DM and 44%with asthma; only data relating
to individuals with DM have been included here (Kuijer et al.,
2007).
Depressive and anxiety symptoms were assessed in all but
one study, which included a QoL outcome (Kuijer et al.,
2007). Depressive symptoms were assessed using the Centre for
Epidemiologic Studies Depression scale (CES-D) in two studies
(Penckofer et al., 2012; Huang et al., 2015), the 9-item Patient
Health Questionnaire (PHQ-9) in two studies (Rosland et al.,
2015; Stoop et al., 2015), and the Beck Depression Inventory
II (BDI) in one study (Moncrieft et al., 2016). Anxiety was
measured in three studies and was assessed using the Crown-
Crisp Experiential Index (CCEI) somatic anxiety subscale in one
study (D’Eramo Melkus et al., 2010), the State Trait Anxiety
Inventory (STAI) in one study (Penckofer et al., 2012) and the
7-item Generalized Anxiety Disorder questionnaire (GAD-7) in
one study (Stoop et al., 2015).
QoL was measured in three studies and was assessed using
the Short-Form 12-item health survey (SF-12) in two studies
(Kuijer et al., 2007; Penckofer et al., 2012) and the Short-Form
36-item health survey (SF-36) in one study (Huang et al., 2015).
Additionally, the Medical Outcomes Study (MOS) survey was
used in one study (D’Eramo Melkus et al., 2010) the QoL Index
Diabetes III Version (QoLd-III) in another study (Penckofer
et al., 2012) and Cantril’s ladder QoL scale (C-QoL) in another
(Kuijer et al., 2007).
Self-efficacy wasmeasured in two studies. One studymeasured
individual’s confidence in their ability to perform a series of
regimen behaviors using the Diabetes Self-efficacy Outcomes
Expectancy Questionnaire (DSEQ) (D’EramoMelkus et al., 2010)
while one study measured self-efficacy using a Self-efficacy beliefs
scale regarding self-management (SESM) and the Summary
of Diabetes Self-Care Activities questionnaire (SDSCA) (Kuijer
et al., 2007).
Other outcomes included social support (D’Eramo Melkus
et al., 2010; Rosland et al., 2015) measured using a subscale
of the Diabetes Care Profile (DCP) (D’Eramo Melkus et al.,
2010; Rosland et al., 2015), HbA1c (D’Eramo Melkus et al.,
2010; Penckofer et al., 2012; Huang et al., 2015; Rosland et al.,
2015; Moncrieft et al., 2016), FBG (D’Eramo Melkus et al., 2010;
Penckofer et al., 2012; Huang et al., 2015) and BMI (D’Eramo
Melkus et al., 2010; Huang et al., 2015).
Two studies had an intervention duration of 12 weeks or
3 months (D’Eramo Melkus et al., 2010; Huang et al., 2015),
two had an intervention duration of 8 weeks (Kuijer et al.,
2007; Penckofer et al., 2012), one of 6 months (Rosland et al.,
2015) and another two studies of 12 months (Stoop et al., 2015;
Moncrieft et al., 2016). The psychosocial interventions in each
study varied in their components, frequency and duration as
shown in Table 2.
Risk of Bias
Table 3 shows that on each of the domains the vast majority of
the included RCTs were rated as having a low or unclear risk
of bias, which is insufficient to justify downgrading the level of
evidence. However, as seen below in the meta-analysis results
and in Supplementary Table 1, heterogeneity exists between
study outcomes for depression symptoms at post intervention
Frontiers in Psychology | www.frontiersin.org 4 December 2017 | Volume 8 | Article 2063
Pascoe et al. Diabetes and Psychosocial Interventions
FIGURE 1 | Flow Chart Showing the Retrieval Process of Trials included in the Meta-analysis.
and QoL at 3 months follow up. This heterogeneity appears to
result from differences in measurement tools and populations
studied, making reliable sub-group analysis difficult. In terms of
PICOs, we consider the population, interventions, comparison
and outcomes to be sufficiently direct to address the question
at hand. In terms of precision, we consider the sample size to
be sufficiently large for the depression (n = 340) and QoL (n
= 267) outcomes. For anxiety symptoms, the total sample was
only n = 151. For self-efficacy, the total sample size was only
n = 140. Finally, in terms of publication bias, a funnel plot of
depressive symptoms indicated potential publication bias. There
were too few studies of anxiety symptoms, QoL and self-efficacy
to assess funnel plots for this outcome reliably. Given the above
considerations, we suggest that the GRADE of evidence should
be downgraded to moderate from high for all outcomes. Table 4
shows the tools used to assess depression, anxiety, self-efficacy
and quality of life in the included studies. In meta-analyses where
the listed tool reads as ‘combined,’ the tools listed in Table 4 were
combined and assessed together in the analysis, for that outcome.
Limitations in Reporting
Assumptions testing of statistical analysis methods were not
reported in four studies (D’Eramo Melkus et al., 2010; Penckofer
et al., 2012; Rosland et al., 2015; Stoop et al., 2015). Implications
for policy were not addressed in six studies (Kuijer et al., 2007;
Penckofer et al., 2012; Huang et al., 2015; Rosland et al., 2015;
Stoop et al., 2015; Moncrieft et al., 2016) and implications for
practice were not addressed in two studies (Kuijer et al., 2007;
D’Eramo Melkus et al., 2010). Strengths and limitations were
not addressed in one study (D’Eramo Melkus et al., 2010) and
whether informed consent was obtained was not specified in two
studies (Kuijer et al., 2007; Rosland et al., 2015). Obtainment of
ethics approval was not specified in one study (Kuijer et al., 2007).
The location of the intervention delivery was not addressed in
two studies (Kuijer et al., 2007; Huang et al., 2015). In two studies
the authors did not specify who collected the outcomes measures
or whether the personal collecting the data were blind to group
assignment (Huang et al., 2015; Rosland et al., 2015; Moncrieft
et al., 2016). In one study, the care setting was not sufficiently
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TABLE 3 | Risk of bias assessment for included studies.
References Random sequence
generation
Allocation
concealment
Blinding of outcome
assessment
Attrition bias Selective reporting Other bias
D’Eramo Melkus et al.,
2010
Low UC Low UC UC High
Kuijer et al., 2007 UC UC UC Low UC Low
Penckofer et al., 2012 Low UC High UC Low Low
Rosland et al., 2015 UC UC Low High UC High
Stoop et al., 2015 Low Low High UC High High
Huang et al., 2015 Low UC UC UC UC Low
Moncrieft et al., 2016 Low Low Low Low High Low
UC, Unclear; Random sequence generation and allocation concealment Two studies did not state the method of randomization (Kuijer et al., 2007; Rosland et al., 2015). Random
sequencing occurred, but with no mention of if allocation concealment was used, in five studies (Kuijer et al., 2007; Penckofer et al., 2012; Huang et al., 2015; Rosland et al., 2015).
In one study, participants were randomized after baseline testing (D’Eramo Melkus et al., 2010). Blinding of outcome assessment In two studies blinding of outcome assessment did
not occur (Penckofer et al., 2012; Stoop et al., 2015). In two studies the authors were contacted and advised that individuals collecting outcome measures were blinded (D’Eramo
Melkus et al., 2010; Rosland et al., 2015). One study failed to provide sufficient information to determine this (Kuijer et al., 2007). Attrition bias Attrition occurred in all studies. One study
performed and reported data for intention-to-treat analysis only, using baseline data to replace missing data (Kuijer et al., 2007). In two studies relevant means and standard deviations
for outcomes of interest were not reported in the text and were provided by the author upon request (completers) (D’Eramo Melkus et al., 2010; Stoop et al., 2015). In three studies,
in text means and standard deviations were provided only for study completers (Penckofer et al., 2012; Huang et al., 2015; Rosland et al., 2015). Means and standard deviations for
study completers only was used in the meta-analysis, except for one study (Kuijer et al., 2007) where only intention-to-treat data was presented. In one study, risk-of-bias due to attrition
was listed as high, as five participants originally randomized to the control group were switched to the intervention group and data was reported as treated rather than as randomized.
Additionally, outcomes were reported for 108 completers from the 183 randomized and the reasons for drop out are not listed (Rosland et al., 2015) Selective reporting Four studies
had previously published protocols (Stoop et al., 2011, 2015; Penckofer et al., 2012). In two of these outcomes listed in the protocol paper were not reported in the trial paper (Stoop
et al., 2015; Moncrieft et al., 2016). Protocols were not available for the remaining four studies (Kuijer et al., 2007; D’Eramo Melkus et al., 2010; Huang et al., 2015; Rosland et al.,
2015). Other bias In one study baseline somatic anxiety scores were higher in participants in the experimental group compared to the UC group (D’Eramo Melkus et al., 2010). In one
study, five of the participants originally randomized to the UC group were switched to the intervention group (Rosland et al., 2015).
TABLE 4 | List of studies and tools used in meta-analysis to examine depression, anxiety, or quality of life.
Study Depression Anxiety Self-Efficacy QoL
SCALES USED
D’Eramo Melkus et al., 2010 CCI DSEQ
Huang et al., 2015 CES-D SF-36 (Physical, Mental Function)
Kuijer et al., 2007 SDSCA, SESM C-QoL, SF-12 (Physical, Mental Function)
Penckofer et al., 2012 CES-D STA-S, STA-T QoL-III (Family, health, overall, psychological socioeconomic),
SF-12 (Physical, Mental Function)
Stoop et al., 2015 PHQ-9 GAD-7
Rosland et al., 2015 PHQ-9
Moncrieft et al., 2016 BDI
PHQ-9, 9-item Patient Health Questionnaire; BDI, Beck Depression Inventory; C-Qol, Cantril’s ladder Quality of life Scale; DSEQ, Diabetes Self-Efficacy Outcomes Expectancies
Questionnaire; GAD-7, General Anxiety Disorder questionnaire; SF-36=(MOS)-SF-36, Medical Outcomes Study; SESM, Self-efficacy beliefs regarding self-management scale; SF-
36, Short form health survey; SF-12, Short form health survey; STAI, State–Trait Anxiety Inventory; STAGI, State–Trait Anger Expression Inventory; SDSCA, Summary of Diabetes
Self-Care Activities questionnaire; CES-D, The Centre for Epidemiological Studies-Depression; QoLd-II, Quality of Life Index—Diabetes III Version.
described and previous articles needed to be accessed to obtain
the missing information (Rosland et al., 2015).
Two studies were underpowered (D’Eramo Melkus et al.,
2010; Moncrieft et al., 2016); another stated that it was
underpowered, but did not provide information about the power
calculations (Kuijer et al., 2007). In one trial information about
power calculations were not provided in text (Stoop et al., 2015)
but the previously published trial paper (Stoop et al., 2011) states
that 80 individuals in both groups would be required to detect a
moderate effect of 0.5 SD on the PHQ-9 and GAD-7, accounting
for attrition, while only 46 were randomized in the RCT (Stoop
et al., 2015).
Meta-Analysis
Depression Outcomes
Figure 2 shows the comparative efficacy of psychosocial
interventions and UC on depressive symptoms. The post-
intervention analysis included five studies. Outcome measures
were the BDI (Moncrieft et al., 2016), CES-D (Penckofer et al.,
2012; Huang et al., 2015) and PHQ-9 (Rosland et al., 2015;
Stoop et al., 2015). The SMD = −0.70 CI = −1.27 to 0.13,
indicating that psychosocial interventions have a medium-large
effect of reducing depression over UC (Z = −2.4, p = 0.02,
Q = 23.70 (4df ), I2= 83.18, T2= 0.34, T = 0.58). One-study
removed sensitivity analysis showed that removal of the study by
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FIGURE 2 | Forest Plot of Psychosocial Interventions on Depressive and Anxious Symptoms by Study. BDI, Beck Depression Inventory II; Combined, Study used a
combination of tools to measure the outcome of interest; CCEI, Crown-Crisp Experiential Index; CES-D, Centre for Epidemiologic Studies-Depression; GAD-7, 7-item
Generalized Anxiety Disorder questionnaire; PHQ-9, 9-item Patient Health Questionnaire; PE, Point Estimate.
Penckofer et al. (Kuijer et al., 2007) resulted in a non-significant
difference between groups (p= 0.06).
At 3 month follow-up, the analysis included two studies
using the CES-D (Penckofer et al., 2012; Huang et al., 2015).
The MD = −8.18, CI = −10.90 to −5.46, Z = −5.89, p <
0.01, Q = 0.02 (1df ), I2, T2, T = 0. Only one study assessed
depressive symptoms at 6 months follow-up, and found that the
psychosocial intervention did not influence depressive symptoms
compared to UC (Rosland et al., 2015).
As the Q statistic indicated that the effect-size varied across
studies post-intervention, we performed a subgroup analysis
comparing outcomes between different depression measures
(only the CES-D and PHQ-9 were compared as only one study
used the BDI). In the two studies that used the CES-D (Penckofer
et al., 2012; Huang et al., 2015), the MD = −7.25, CI = −10.01
to −4.49. Conversely, for the two studies that used the PHQ-9
(Rosland et al., 2015; Stoop et al., 2015),MD=−1.06,CI=−3.46
to −1.34. This shows that the effect size was higher in studies
measuring depression using the CES-D compared to the PHQ-9.
This may be why significant differences were also seen at 3 month
follow-up, in the studies that used the CES-D (Penckofer et al.,
2012; Huang et al., 2015), but not in the study with the 6 month
follow-up, in which the PHQ-9 was used (Rosland et al., 2015).
The four studies evenly contributed to the reported outcomes
(20–27% each).
Anxiety Outcomes
As shown in Figure 2, the analysis of anxiety symptoms post-
intervention includes three studies using the STAI (composite
score of STAI-T and STAI-S) (Penckofer et al., 2012), CCEI
(D’Eramo Melkus et al., 2010), and GAD-7 (Stoop et al., 2015).
At post-intervention, the SMD = −0.30, CI = −0.69 to 0.10
(Z = −1.73, p = 0.08, Q = 2.69(2df ), I2= 25.67, T2= 0.03,
T = 0.18). One trial contributed 14%, (Stoop et al., 2015)
while two contributed over 38 and 36% (D’Eramo Melkus et al.,
2010; Penckofer et al., 2012). Therefore, two studies are largely
responsible for the findings. One-study removed sensitivity
analysis showed that removal of the study by D’Eramo Melkus
et al. (Michie et al., 2011) resulted in a significant difference
between groups (p= 0.03).
At 3 month follow-up two studies measured anxiety
outcomes, one using the CCEI (D’Eramo Melkus et al., 2010)
and the other using the STAI (Penckofer et al., 2012), the SMD=
−0.61,CI=−0.92 to−0.31, Z=−3.93, p= 0.00,Q= 0.15 (1df ),
I2, T2, and T = 0. Thus, psychosocial interventions decreased
anxious symptoms at 3 months follow-up compared to UC.
At 6 month follow-up two studies measured anxiety
outcomes, one using the CCEI (D’EramoMelkus et al., 2010) and
the other using the GAD-7 (Stoop et al., 2015), SMD=−0.47, CI
= −0.98 to 0.03, Z = −1.85, p = 0.06, Q = 1.04 (1df ), I2= 3.81,
T2 = 0.01, T = 0.08, demonstrating that the decrease in anxious
symptoms was not sustained at 6 month follow-up.
Quality of Life Outcomes
As shown in Figure 3, three studies measured QoL at post-
intervention using the SF-36 (Huang et al., 2015), SF-12 (Kuijer
et al., 2007; Penckofer et al., 2012), C-QoL (Kuijer et al., 2007) and
QoLd-III (Penckofer et al., 2012). A composite mean score was
used. The SMD = 0.30, CI = 0.06–0.55, Z = 2.44, p = 0.02, Q =
1.20 (3df ), I2, T2, T = 0. One-study removed sensitivity analysis
showed that removal of Huang et al. (Penckofer et al., 2012),
(SMD = 0.24, p = 0.10) or Penckofer et al. (Kuijer et al., 2007),
(SMD = 0.39, p = 0.08) resulted in a non-significant difference
between groups. One study contributed 49% (Penckofer et al.,
2012) and two studies contributed 28% (Kuijer et al., 2007) and
23% (Huang et al., 2015) of the weight of the results.
At 3 month follow-up, the analysis included three studies
using the SF-36 (Huang et al., 2015), MOS-SF-36 (D’Eramo
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FIGURE 3 | Forest Plot of Psychosocial Interventions on Quality of Life and Self-Efficacy Symptoms by Study. DSEQ, Diabetes Self-Efficacy Outcomes Expectancies
Questionnaire; Combined, Study used a combination of tools to measure the outcome of interest; PE, Point Estimate; QoL, Quality of life.
Melkus et al., 2010) SF-12 and QoLd-III (Penckofer et al., 2012).
The SMD = 0.52, CI = 0.10–0.95, Z = 2.40, p = 0.02, Q = 4.95
(2df ), I2 = 59.62, T2= 0.08, T = 0.29. Only one study assessed
QoL outcomes at 6 month follow-up (Kuijer et al., 2007).
Self-efficacy Outcomes
Figure 3 shows that at post-intervention the analysis of
self-efficacy (relating to disease management) outcome was
completed in two studies, one using the DSEQ (D’Eramo Melkus
et al., 2010) and the other using a SESM and the SDSCA (Kuijer
et al., 2007). The SMD = 0.23, CI = −0.11 to 0.57, Z = 1.35,
p = 0.18, Q = 0.27 (1df ), I2, T2, and T = 0. Therefore, the
psychosocial interventions do not appear to influence beliefs of
self-efficacy. Both studies contributed equally to the outcomes;
47% (Kuijer et al., 2007) vs. 53% (D’Eramo Melkus et al., 2010).
Only one study (D’Eramo Melkus et al., 2010) explored self-
efficacy at 3 month follow-up and found no significant difference
between groups. At 6 month follow-up, two studies assessed self-
efficacy (Kuijer et al., 2007; D’Eramo Melkus et al., 2010) and did
not find a significant difference between groups, SMD = 0.19, CI
=−0.19 to 0.57, Z = 1.0, p= 0.32, Q= 0.57 (1df ), I2, T2, T = 0.
Other Outcomes
BMI was measured in two studies post-intervention (D’Eramo
Melkus et al., 2010; Huang et al., 2015),MD=−1.46, CI =−4.64
to 1.72, Z = −0.90, p = 0.37, Q = 0.02 (1df ), I2, T2, and T = 0.
HbA1c was measured in five studies post-intervention (D’Eramo
Melkus et al., 2010; Penckofer et al., 2012; Huang et al., 2015;
Rosland et al., 2015; Moncrieft et al., 2016), MD = −0.15, CI =
−0.65 to 0.06, Z =−0.58, p= 0.56, Q= 4.27 (4df), I2 = 6.32, T2
= 0.02 and T = 0.15. Social support was measured in two studies
using the DCP post-intervention (D’Eramo Melkus et al., 2010;
Rosland et al., 2015), MD = 0.09, CI = −0.36 to −0.53, Z =
0.38, p = 0.71, Q = 0.44 (1 df ), I2, T2, and T = 0. Therefore,
psychosocial interventions did not appear to influence BMI,
HbA1c or social support post-intervention. No changes were
seen at follow-up (not reported) for BMI or HbA1c and only one
study assessed social support at follow-up. FBG was measured
in three studies (D’Eramo Melkus et al., 2010; Penckofer et al.,
2012; Huang et al., 2015) and at post-intervention the MD =
−26.18, CI = −51.58 to −0.79, Z = −2.02, p = 0.04, Q = 1.17
(2df ), I2, T2, and T = 0. Therefore, psychosocial interventions
appeared to decrease fasting glucose. Similar effects were seen at
3 month follow-up, MD = −29.69, CI = −56.24 to −3.15, Z =
−2.19, p = 0.03, Q = 1.49 (2df ), I2, T2, and T = 0. Only one
study (D’Eramo Melkus et al., 2010) explored fasting glucose at
6 month follow-up, and found no significant difference between
groups.
DISCUSSION
This systematic review andmeta-analysis found that psychosocial
interventions, compared to UC, reduce depressive symptoms
in individuals with diabetes and that these effects persist at
3 month follow-up. The magnitude of the standardized mean
difference reflects a medium-large benefit of the intervention.
Subgroup analysis of depression outcomes show that the effect-
size was larger in studies measuring depression using the CES-
D compared to the PHQ-9. The efficacy and accuracy of the
CES-D and PHQ-9, in comparison with clinical interview, has
previously been assessed a study involving 185 individuals with
type II diabetes (Khamseh et al., 2011). The authors reported
that while using the PHQ-9, 47.6% of individuals were diagnosed
with major depressive disorder, while 61.62% were diagnosed
while using the CES-D. These results indicate that the CES-D
may be more sensitive than the PHQ-9 at identifying depressive
symptoms in people with diabetes.
Anxiety symptoms were not found to decrease post-
intervention, but were decreased at 3 month follow-up. This is
likely to reflect that fact that the 3 month assessment did not
include the study using the CCEI measure of somatic anxiety
(D’Eramo Melkus et al., 2010), which is arguably quite different
from state, trait and generalized anxiety. Indeed, one-study
removed analysis showed that removal of the aforementioned
study using the CCEI measure (D’Eramo Melkus et al.,
2010) resulted in a small-medium benefit of the intervention
between groups directly post-intervention. Additionally, there
was significant variation between the psychosocial interventions,
including the mode of delivery, the individual delivering the
intervention, the setting, frequency and duration of session and
most likely the therapeutic alliance. These differences likely
contribute to the statistical heterogeneity seen in effect sizes for
some outcomes. In addition, the results of our study indicate
that psychosocial interventions may offer a small benefit in terms
of QoL.
Frontiers in Psychology | www.frontiersin.org 11 December 2017 | Volume 8 | Article 2063
Pascoe et al. Diabetes and Psychosocial Interventions
The beneficial effect seen in depressive symptoms is consistent
with a previous meta-analysis of psychosocial interventions with
individuals with coronary heart disease that found a reduction
in depressive and anxious symptoms (Ski et al., 2015). However,
in this previous study, psychosocial interventions were seen to
have a small benefit for depressive symptoms (SMD = 0.15)
and a medium to large benefit for anxiety symptoms (SMD =
0.76). Our current results indicate that the effect of psychosocial
intervention on reducing depression and anxiety are greater
in a DM population compared to a coronary heart disease
population. As we reported SMD rather than mean difference
in the current meta-analysis, the clinical significance of these
effect sizes is not inherently meaningful. The effect size can be
interpreted as the probability of patients in the intervention
group improving over and above a patient receiving usual
care (Faraone, 2008). Our effect size for depressive symptoms
was small and for anxiety symptoms it was medium to large,
meaning that the decrease in depressive symptoms resulting
from psychosocial interventions is likely to be small, and
the decrease in anxiety symptoms resulting from psychosocial
interventions is likely to be medium to large. There are a number
of limitations to our meta-analysis. A number of the primary
studies are characterized by a small sample size. There was
also heterogeneity in terms of the data collection schedules
in the primary studies, and some trials did not collect some
outcomes directly post-intervention; only at baseline and follow-
up. There was also significant heterogeneity between the studies
in terms of what constituted a psychosocial intervention, and
often the interventions were not sufficiently described to facilitate
replication. This likely reflects the developing nature of this
field. Indeed, very few studies were identified that investigated
the effects of psychosocial interventions, compared to UC, in a
DM population. We see the small number of identified studies
in the current meta-analysis as a testimony to the need for
further research in this field. Indeed, previously published meta-
analyses have similarly included a limited number of studies
due to the lack of research in the field on inquiry (Charidimou
et al., 2013; Cleland et al., 2013; Menon et al., 2013; Goyal
et al., 2016). Depression symptoms were only assessed in five
studies, anxiety and QoL in three, and self-efficacy in two
studies. Thus the reported findings should be interpreted with
caution. A final limitation of the current meta-analysis is that
in five studies (Kuijer et al., 2007; D’Eramo Melkus et al.,
2010; Huang et al., 2015; Rosland et al., 2015; Moncrieft et al.,
2016), it was not specified whether some participants received
antidepressant or anxiolytic treatment during the course of the
intervention. In one study (Penckofer et al., 2012), participants
who reported using psychoactive medications prior to entry
into the study remained on these while participating in the
study, and the authors highlighted that there was no significant
difference in self-reported use of psychoactive medications
between the intervention and control groups. In another study
(Stoop et al., 2015) the use of pharmacotherapy was not an
exclusion criterion and the authors noted that they did not have
information about any potential dose changes in participants
using pharmacotherapy and therefore were unable to control
for this in the analyses. Thus, the potential confounding role
of pharmaceutical anti-depressant medication in the primary
studies is largely unknown.
While some studies have assessed the impact of lifestyle
interventions and psychological interventions on wellbeing in
people with DM, to our knowledge this is the first meta-analysis
to assess the effectiveness of psychosocial interventions, being
interventions with both a psychological and social component,
in a DM population. The results of our meta-analysis indicate
that various psychosocial interventions appear effective for the
management of depressive symptoms and may improve QoL. In
future studies it would be useful to include a cost-benefit analysis
to determine if such psychosocial interventions are cost-effective,
compared to usual care. The limited number of studies in this
meta-analysis highlights the need for additional research in this
field, to confirm or refute the current encouraging findings and
to explore what type of psychosocial interventions may be most
effective.
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